Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities
AbstractAnalyses of sequences and structures of the cyclosporine A (CsA)-binding proteins (cyclophilins) and the immunosuppressive macrolide FK506-binding proteins (FKBPs) have revealed that they exhibit peculiar spatial distributions of charges, their overall hydrophobicity indexes vary within a considerable level whereas their points isoelectric (pIs) are contained from 4 to 11. These two families of peptidylprolyl cis/trans isomerases (PPIases) have several distinct functional attributes such as: (1) high affinity binding to some pharmacologically-useful hydrophobic macrocyclic drugs; (2) diversified binding epitopes to proteins that may induce transient manifolds with altered flexibility and functional fitness; and (3) electrostatic interactions between positively charged segments of PPIases and negatively charged intracellular entities that support their spatial integration. These three attributes enhance binding of PPIase/pharmacophore complexes to diverse intracellular entities, some of which perturb signalization pathways causing immunosuppression and other system-altering phenomena in humans. View Full-Text
- Supplementary File 1:
Supplementary (ZIP, 5867 KB)
Share & Cite This Article
Galat, A. Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities. Biomolecules 2017, 7, 72.
Galat A. Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities. Biomolecules. 2017; 7(4):72.Chicago/Turabian Style
Galat, Andrzej. 2017. "Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities." Biomolecules 7, no. 4: 72.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.